HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia
← catalyst calendarNCT07659366 · readout in 316 d
Sponsored by Nexalin Technology (industry) · NXL — their whole pipeline →. With Lindus Health.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
160estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-22 | estimated | When the study began enrolling |
| Primary completion | 2027-07-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-10-25 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-22 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Moderate to Severe Insomnia
Intervention
- Device: Transcranial alternating current stimulator — also filed as Active Arm Intervention Name: HALO Clarity™ Active Device., Sham Arm Intervention Name: HALO Clarity™ Sham Device
Primary outcome
what the primary-completion date above is the date OFChange in Insomnia Severity Index (ISI) Total Score at Week 4
measured 4 weeks after treatment initiation.
Publications
- PMID 36115372 — cited as background
- PMID 31846980 — cited as background
- PMID 35353887 — cited as background
- PMID 38176353 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · NXL's whole pipeline · Catalyst calendar · Every registered study · What changed